These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 5890076)

  • 1. [Changes in the catalase index in asthenic neurosis as related to prolonged treatment with glucose].
    Corfariu O; Csontos A
    Neurol Psihiatr Neurochir; 1965; 10(1):45-8. PubMed ID: 5890076
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes caused by adrenaline in blood catalase activity in relation to the administration of glucose in neurotics].
    Corfariu O; Csontos A
    Neurol Psihiatr Neurochir; 1966; 11(5):441-6. PubMed ID: 5976694
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood catalase alterations in employees working with organic solvents.
    Csontos A; Dienes A; Szabo Z
    Rom Med Rev; 1968; 12(4):6-10. PubMed ID: 5703536
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ocular disturbances in asthenic neurosis and their treatment (author's transl)].
    Vancea P
    Klin Monbl Augenheilkd; 1977 Apr; 170(4):525-8. PubMed ID: 18637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Indications for a monoamine oxidase inhibitor hydrazine (nialamide) in the treatment of asthenic and hypochondriac neuroses. (Apropos of 70 ambulatory treatments)].
    Leyrie J
    Ann Med Psychol (Paris); 1965 May; 123(5):745-9. PubMed ID: 5834684
    [No Abstract]   [Full Text] [Related]  

  • 6. [The glucose tolerance test in patients suffering from asthenic neurosis].
    PINTILIE C; RADOVICH V; STOICA I
    Rev Sci Med; 1961; 6():201-5. PubMed ID: 14486793
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental research on suggestibility of patients with asthenic neurosis].
    Gheorghiu V; Meiu G; Negrea G; Onofrei A; Pătraşcu F; Pungă C
    Neurol Psihiatr Neurochir; 1966; 11(4):289-94. PubMed ID: 5981728
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anamnestic aspects of patients with the diagnosis of asthenic neurosis].
    Parhon-Stefănescu C; Rodin Z; Procopiu-Constantinescu T
    Neurol Psihiatr Neurochir; 1966; 11(3):241-8. PubMed ID: 5982135
    [No Abstract]   [Full Text] [Related]  

  • 9. [Asthenic neurosis].
    Kreĭndler A
    Klin Med (Mosk); 1973 Jan; 51(1):31-5. PubMed ID: 4764837
    [No Abstract]   [Full Text] [Related]  

  • 10. [Characteristics of ladasten effect in neurasthenia patients with various EEG parameters].
    Neznamov GG; Bochkarev VK; Siuniakov SA; Grishin SA
    Eksp Klin Farmakol; 2008; 71(4):18-25. PubMed ID: 18819436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aspects of the etiological contellation in asthenic neurosis].
    Belciugăţeanu C; Ionescu G; Braslă N; Elias S; Diacicov S; Timofte G; Florescu D; Popescu V; Wolcz V; Teodorescu M; Covalev-Ioniţă X
    Neurol Psihiatr Neurochir; 1968; 13(3):255-62. PubMed ID: 5696340
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical peculiarities of asthenic and dysthymic neurosis-like disorders in patients with alcoholism].
    Kolupaev GP; Chebotkov AA
    Voen Med Zh; 2000 Jul; 321(7):34-9. PubMed ID: 12886534
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preliminary report of the therapeutic results of blood transfusion in asthenic neurosis].
    ANGHELESCU C; BOTEZ M; NICOLAU A; RADULESCU G
    Med Interna (Bucur); 1956; 8(2):277-83. PubMed ID: 13399623
    [No Abstract]   [Full Text] [Related]  

  • 14. [Сlinical and physiological characteristics and therapy asthenic disorders in adolescents girls].
    Rodionova EY; Chutko LS; Surushkina SY; Yakovenko EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(4):68-70. PubMed ID: 28617383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the kinematic viscosity and surface tension on the bubble take-off period in a catalase-hydrogen peroxide system.
    Sasaki S; Iida Y
    Colloids Surf B Biointerfaces; 2009 Jun; 71(1):124-7. PubMed ID: 19250805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Variations of the catalase index in essential arterial hypertension].
    Csontos A; Jaklovszky D
    Med Interna (Bucur); 1966 May; 18(5):607-12. PubMed ID: 5924376
    [No Abstract]   [Full Text] [Related]  

  • 17. [Electrophoresis of drugs with pulsating low-frequency current (electronarcosis technique) in the treatment of patients with neurasthenia].
    Izakson KhA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1969; 34(6):546-7. PubMed ID: 5379583
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitrite production by stimulated human polymorphonuclear leukocytes supplemented with azide and catalase.
    Klebanoff SJ; Nathan CF
    Biochem Biophys Res Commun; 1993 Nov; 197(1):192-6. PubMed ID: 8250925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of the selective anxiolytic agent afobazol].
    Neznamov GG; Siuniakov SA; Chumakov DV; Bochkarev VK; Seredenin SB
    Eksp Klin Farmakol; 2001; 64(2):15-9. PubMed ID: 11548440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised, double-blind, placebo-controlled study of pivagabine in neurasthenia.
    Pizzolato G; Cagnin A; Mancia D; Caffarra P; Avanzi S; Copelli S; Ciappina C; Lo Presti F; Spilimbergo PG; D'Antonio E; Di Costanzo E; Matrango M; Pastres P; Urbani PP; Signorino M; Simoncelli M; Provinciali L; Regnicolo L; Albano C; Roccatagliata G; Rubino V; Cultrera S; Fracassi M
    Arzneimittelforschung; 1997 Nov; 47(11A):1329-31. PubMed ID: 9450159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.